Insulinoma: Difference between revisions
| Line 41: | Line 41: | ||
==Treatment== | ==Treatment== | ||
[[Insulinoma medical therapy|Medical therapy]] | [[Insulinoma surgery|Surgical options]] | [[Insulinoma primary prevention|Primary prevention]] | [[Insulinoma secondary prevention|Secondary prevention]] | [[Insulinoma cost-effectiveness of therapy|Financial costs]] | [[Insulinoma future or investigational therapies|Future therapies]] | [[Insulinoma medical therapy|Medical therapy]] | [[Insulinoma surgery|Surgical options]] | [[Insulinoma primary prevention|Primary prevention]] | [[Insulinoma secondary prevention|Secondary prevention]] | [[Insulinoma cost-effectiveness of therapy|Financial costs]] | [[Insulinoma future or investigational therapies|Future therapies]] | ||
==Prognosis== | ==Prognosis== | ||
Revision as of 15:08, 17 January 2012
For patient information click here
| Insulinoma | |
.jpg) | |
|---|---|
| Histopathology of pancreatic endocrine tumor (insulinoma). | |
| ICD-10 | C25.4, D13.7 |
| ICD-9 | 157.4, 211.7 |
| ICD-O: | 8151 |
| DiseasesDB | 6830 |
| MeSH | D007340 |
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma On the Web |
|
American Roentgen Ray Society Images of Insulinoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Historical Perspective
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes
Differentiating Insulinoma
Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics
Treatment
Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies
Prognosis
Most patients with benign insulinomas can be cured with surgery. Persistent or recurrent hypoglycemia after surgery tends to occur in patients with multiple tumours. About two percent of patients develop diabetes mellitus after their surgery.
History
Hypoglycemia was first recognized in the 19th century. In the 1920’s, after the discovery of insulin and its use in the treatment of diabetics, hyperinsulinism was suspected to be a cause of hypoglycemia in non-diabetics. The first report of a surgical cure of hypoglycemia by removing an islet cell tumour was in 1929.
See also
External links
Template:Tumor morphology de:Insulinom he:אינסולינומה nl:Insulinoom fi:Insulinooma